| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/04/2010 | WO2010014895A2 Nanoparticle compositions for nucleic acids delivery system |
| 02/04/2010 | WO2010014572A2 Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| 02/04/2010 | WO2010014567A2 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| 02/04/2010 | WO2010014218A2 Puf-a and related compounds for treatment of retinopathies and sight-threatening ophthalmologic disorders |
| 02/04/2010 | WO2010013846A1 New therapeutic agent for malignant mesothelioma and immunostimulant |
| 02/04/2010 | WO2010013633A1 Methods for prediction of rb status and sensitivity to plk1 inhibitor of cell |
| 02/04/2010 | WO2010012829A1 Her2/neu specific t cell receptors |
| 02/04/2010 | WO2010012472A1 Improved pre-mrna trans-splicing molecule (rtm) molecules and their uses |
| 02/04/2010 | WO2010012244A1 Small rna interference target site sequences of hepatitis b virus and small interference rnas and the compositions and uses thereof |
| 02/04/2010 | WO2010012088A1 Apparatus and method for loading and transporting containers |
| 02/04/2010 | WO2009151503A9 Compositions and methods for the treatment of a neoplasia |
| 02/04/2010 | WO2009097077A3 Wound healing compositions and treatments |
| 02/04/2010 | WO2003076575A9 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 02/04/2010 | US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 02/04/2010 | US20100029751 Compositions comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis |
| 02/04/2010 | US20100029747 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 02/04/2010 | US20100029746 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes |
| 02/04/2010 | US20100029510 siRNA targeting survivin |
| 02/04/2010 | US20100028431 Compositions and methods for therapeutic use |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028370 Megalin-based delivery of therapeutic compounds to the brain and other tissues |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028328 Topical treatment for diseases of eye surface |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028260 Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
| 02/04/2010 | CA2732142A1 Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| 02/03/2010 | EP2149604A1 Collections of repeat proteins comprising repeat modules |
| 02/03/2010 | EP2149584A1 Method for enhancing immune response with peptide |
| 02/03/2010 | EP2149381A2 Method of treating malignancies through induction of blood immune responses |
| 02/03/2010 | CN101637611A Ocular gene therapy |
| 02/02/2010 | US7655788 Short interfering RNA sequences for use in treatment and prevention of cell proliferative, diabetic and nervous system disorders |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655779 Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences |
| 02/02/2010 | US7655773 Arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases |
| 02/02/2010 | US7655772 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655755 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 02/02/2010 | US7655635 Suppression of nuclear factor-κB dependent processes using oligonucleotides |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655468 Noncovalent complex having net positive charge at pH 6.0-8.0, the complex comprising a nucleic acid, at least one cationic lipid, and a polycation, where polycation is a cationic peptide or a polypeptide comprising polylysine, polyornithine, or polyarginine; gene therapy |
| 02/02/2010 | US7655467 vascular permeability agents (VPAs), such as VEGF, used in conjunction with adeno-associated virus(AVV) a nucleic acid viral vectors; nucleic cid sequences encoding Igf-1( insulin like growth factor-1) and dystrophin or dystrophin-like proteins; muscular disorders |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655441 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/02/2010 | US7655435 For eukaryotic in vitro expression; silicone-based surfactants and microcapsules; phage display |
| 02/02/2010 | US7655432 Nucleotide sequences coding serine/threonine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655426 Ephrin-B receptor protein involved in carcinoma |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655420 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 02/02/2010 | US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 02/02/2010 | US7655398 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 02/02/2010 | US7655249 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655241 Methods and compositions for vaccination against or involving enterobacteriaceae bacteria |
| 02/02/2010 | US7655224 Neural stem cells and use thereof for brain tumor therapy |
| 02/02/2010 | CA2585164C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 02/02/2010 | CA2428214C Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/01/2010 | CA2638190A1 Treatment of als |
| 01/28/2010 | WO2010011281A2 Methods and compositions for the diagnosis and treatment of cancer |
| 01/28/2010 | WO2010010208A1 siRNA AND shRNA FOR THE PRODUCTION OF DRUGS FOR HIGH INTRAOCULAR PRESSURE |
| 01/28/2010 | WO2010009905A1 Cancer treatment and test |
| 01/28/2010 | WO2010009534A1 Methods for the treatment, prevention and diagnosis of lipid metabolism associated diseases |
| 01/28/2010 | WO2009126789A3 Engineering and delivery of therapeutic compositions of freshly isolated cells |
| 01/28/2010 | WO2006138675A9 Her-2 peptides |
| 01/28/2010 | US20100022756 Trimerising Module |
| 01/28/2010 | US20100022016 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021456 Drug for inhibiting,preventing or treatment of rheumatoid arthritis |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | CA2762118A1 Vectors for delivery of light-sensitive proteins and methods of use |
| 01/28/2010 | CA2690828A1 Composition containing microrna-21 inhibitor for enhancing radiation sensitivity |
| 01/27/2010 | EP2147681A1 Compositions and methods for treating lysosomal storage disease |
| 01/27/2010 | EP2147103A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 01/27/2010 | EP2146727A1 High viscosity macromolecular compositions for treating ocular conditions |
| 01/27/2010 | EP1319713B1 Complex |
| 01/27/2010 | EP1206563B1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 01/27/2010 | CN101632836A DNA vaccine for Edwardsiella tarda and construction and application thereof |
| 01/27/2010 | CN101632663A Novel molecular target for neurotoxicity |
| 01/27/2010 | CN100584948C Procine circoviruses, vaccines and diagnostic reagents |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584331C Use of immunomudulatory compounds in preparing medicine for the treatment, control or prevention of myeloproliferative diseases |
| 01/26/2010 | US7651998 administering a Venezuelan Equine Encephalitis (VEE) vector (alpha virus vector) comprising a heterologus nucleotide sequence to a subject; concurrently administering an antibody that specifically binds to the E1 and/or the E2 glycoprotein of the VEE vector to produce immune response to cancer patient |
| 01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 01/26/2010 | US7651656 Melting furnace with agitator and agitator for melting furnace |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2404237C Methods of investigating, diagnosing, and treating amyloidosis |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/21/2010 | WO2010009312A2 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 01/21/2010 | WO2010009122A1 Medical devices and methods for delivery of nucleic acids |
| 01/21/2010 | WO2010008576A2 Idna vaccines and methods for using the same |
| 01/21/2010 | WO2010008568A1 Tm4sf4 and modulators thereof and methods for their use |
| 01/21/2010 | WO2010008474A2 Methods for treating multiple sclerosis using antisense oligonucleotides |